Results 31 to 40 of about 946,596 (283)

Circadian stage-dependent and stimulation duration effects of transcutaneous auricular vagus nerve stimulation on heart rate variability.

open access: yesPLoS ONE, 2022
Transcutaneous auricular vagus nerve stimulation (taVNS) can improve autonomic nerve function and is currently undergoing extensive clinical research; however, its efficacy heterogeneity has caused great controversy.
Duyan Geng   +5 more
doaj   +1 more source

Vagal nerve stimulation in heart failure [PDF]

open access: yesEuropean Heart Journal, 2014
This editorial refers to ‘Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the Neural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial’[†][1], by F. Zannad et al. , on page 425. It has been estimated that the prevalence of heart failure with a reduced ejection fraction exceeds 20 ...
A John, Camm, Irina, Savelieva
openaire   +2 more sources

Preganglionic innervation of the pancreas islet cells in the rat [PDF]

open access: yes, 1984
The position and number of preganglionic somata innervating the insulin-secreting β-cells of the endocrine pancreas were investigated in Wistar rats.
Steffens, A.B.,   +14 more
core   +1 more source

Noninvasive vagus nerve stimulation in the management of cluster headache: clinical evidence and practical experience

open access: yesTherapeutic Advances in Neurological Disorders, 2016
The efficacy of invasive vagal nerve stimulation as well as other invasive neuromodulatory approaches such as deep brain stimulation, occipital nerve stimulation, and ganglion sphenopalatine stimulation has been shown in the treatment of headache ...
Dagny Holle-Lee, Charly Gaul
doaj   +1 more source

Can the vagus nerve serve as biomarker for vata dosha activity?

open access: yesJournal of Ayurveda and Integrative Medicine, 2019
This ‘discussion paper’ raises ‘provocative questions’ to identify physiological systems underlying vata dosha and candidate biomarkers for vata activity.
Venil N. Sumantran, Pratibha P. Nair
doaj   +1 more source

Preliminary findings of cerebral responses on transcutaneous vagal nerve stimulation on experimental heat pain. [PDF]

open access: yes, 2017
Transcutaneous vagal nerve stimulation (TVNS) is a promising complementary method of pain relief. However, the neural networks associated with its analgesic effects are still to be elucidated.
Lotze, Martin   +3 more
core   +2 more sources

Selective optogenetic stimulation of efferent fibers in the vagus nerve of a large mammal [PDF]

open access: yes, 2020
BACKGROUND: Electrical stimulation applied to individual organs, peripheral nerves, or specific brain regions has been used to treat a range of medical conditions.
Hood, SG   +20 more
core   +1 more source

The Gut–Heart Axis in Systemic Sclerosis: Evidence From a Large Prospective Early Disease Cohort

open access: yesArthritis Care &Research, EarlyView.
Objective Cardiac involvement significantly impacts prognosis in systemic sclerosis (SSc), highlighting the need for early risk stratification. Gastrointestinal (GI) symptoms are common and often manifest early. Emerging data suggest a link between GI and cardiac manifestations, possibly through shared mechanisms like dysautonomia.
Francesca R. Di Ciommo   +9 more
wiley   +1 more source

Optogenetic stimulation of cholinergic fibers for the modulation of insulin and glycemia

open access: yesScientific Reports, 2021
Previous studies have demonstrated stimulation of endocrine pancreas function by vagal nerve electrical stimulation. While this increases insulin secretion, expected concomitant reductions in circulating glucose do not occur. A complicating factor is the
Arjun K. Fontaine   +9 more
doaj   +1 more source

Randomized Cross Over Study Assessing the Efficacy of Non-invasive Stimulation of the Vagus Nerve in Patients With Axial Spondyloarthritis Resistant to Biotherapies: The ESNV-SPA Study Protocol

open access: yesFrontiers in Human Neuroscience, 2021
Axial spondyloarthritis (SpA), is a major cause of chronic pain and disability that profoundly alters the quality of life of patients. Nearly half of patients with SpA usually develop drug resistance. Non-pharmacological treatments targeting inflammation
Eric Azabou   +18 more
doaj   +1 more source

Home - About - Disclaimer - Privacy